More Avecho Biotechnology Limited news
Avecho Biotechnology LimitedASX: AVE

June 2020 Quarterly Activities Report & Appendix 4C

Jul 28, 2020 at 1:45 AM EDT · Issued by Avecho Biotechnology Limited

Filed with ASX · Jul 28, 2020 at 1:45 AM EDT

On 6ix: 6ix.com/news/june-2020-quarterly-activities-report-and-appendix-4c

Avecho Biotechnology Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Avecho Biotechnology Limited on 6ix

Story so far

  • March 2020 Quarterly Activities Report & Appendix 4CApr 29, 2020
  • Appendix 4E and Annual Report 31 December 2019Mar 2, 2020
  • Appendix 4C - QuarterlyJan 23, 2020

Earlier from Avecho Biotechnology

  • March 2020 Quarterly Activities Report & Appendix 4CApr 28, 2020
  • Changes to Leadership TeamApr 26, 2020
  • Medicinal cannabis supply agreement with Tasmanian AlkaloidsApr 26, 2020
  • Avecho signs Term Sheet for Cannabinoid Supply with PurisysApr 13, 2020
  • Appendix 4E and Annual Report 31 December 2019Mar 1, 2020

Later from Avecho Biotechnology

  • Progress Update for TPM Cannabinoid Development ProgramAug 19, 2020
  • TPM Cannabinoid Development Program UpdateOct 18, 2020
  • September 2020 Quarterly Activities Report & Appendix 4COct 28, 2020
  • Improved Propofol TPM Formulation Passes Toxicology StudyNov 3, 2020
  • AVE begins Human Trial on CBD productDec 22, 2020
All Avecho Biotechnology news releases↗

Follow Avecho Biotechnology into a list and get an email when it puts out news.

Follow Avecho Biotechnology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer